Webinars
Webinar – SMARTag® Technology, from Bertozzi Lab to Best-in-Class ADCs
In this webinar, Chemistry Nobel Laureate, Carolyn Bertozzi, Ph.D., Professor, Stanford University, Penelope Drake, Ph.D., Head of R&D, Bioconjugates, Catalent Biologics, and Seema Kantak, Ph.D., Senior Vice President, Biotherapeutics, Exelixis, discuss the latest trends in ADC discovery and development.
View Now
Webinars
Webinar – Overcoming Formulation Challenges for mRNA and High-Concentration Proteins
In this webinar, experts will discuss how to improve the formulation development of high-concentration mAbs for subcutaneous delivery to reduce viscosity, and potentially reduce costs and timelines, and how to overcome current challenges met in formulating mRNA lipid nanoparticles (mRNA-LNP).
View Now
Offering Fact Sheet
Drug Product Manufacturing in Anagni – Infocard
Catalent’s Anagni facility is a world-class, late-stage and commercial product launch site offering sterile and biologics manufacturing & secondary packaging with extensive expertise in aseptic liquid vial filling.
View Now
Offering Fact Sheet
Drug Product Manufacturing in Limoges – Infocard
Catalent Biologics' Limoges, France site is our European center of excellence for early phase clinical biologics formulation development and drug product fill/finish. The site offers an integrated facility with a small-scale filling line, in-house analytical capabilities, quality control labs, cold storage, and regulatory support.
View Now
Article
Biopharma 4.0 – Spearheading Digital Transformation in the Biopharmaceutical Industry
Summary: For Contract Development and Manufacturing Organizations (CDMOs), transitioning to Biopharma 4.0 is crucial – the data and expertise amassed by these manufacturers represent an integral asset for their customers working to innovate in an increasingly competitive and fast-paced market.
View Now
Executive Summary
The Keys to Success when Switching from Vials to Prefilled Syringes and Intravenous to Subcutaneous Formulations for Biologics
This article describes the benefits of transitioning from IV to SQ administration, considers the advantages of using PFSs, and explores challenges and solutions for transitioning from vials to PFS.
View Now
Podcast
Podcast: Obstacles & Opportunities in Orphan Biologics- From Development to Production and Supply
Summary: In this podcast, experts discuss how to overcome obstacles that span from discovery to launch of orphan drugs as well as discuss the needs of patients and drug developers in orphan biologics development.
View Now
Webinars
Formulation Strategies Moving from Intravenous to Subcutaneous and from Vial to PFS
Summary: In this webinar, experts discuss the formulation development challenges, considerations, and potential solutions associated with...
View Now
Webinars
The Post-COVID Supply Chain
Summary: During this panel discussion, executives share how their companies adapted to the challenges and what lessons they will take forward to ensure...
View Now
Webinars
Catalent’s Chair and CEO Shares His Views About Drug Development and Manufacturing in a Pandemic
Summary: In December 2021, John Chiminski was featured on the expert panel of STAT’s "A Look Ahead at Biotech in 2022" event, which focused on the ongoing battle against the SARS-CoV-2 virus and explored what might be in store for the biotech industry in the years to come.
View Now
